S Soga Selected Research

KT 1 (KT-1)

7/2001	Development of interferon-alpha resistant subline from human chronic myelogenous leukemia cell line KT-1.
1/2000	Sensitivity to interferon-alpha and interferon-stimulated gene factor 3 binding activity in human chronic myelogenous leukemia cell line KT-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Soga Research Topics

Disease

4	Neoplasms (Cancer) 04/2012 - 07/2001
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2001 - 01/2000
2	Breast Neoplasms (Breast Cancer) 12/2001 - 12/2001
1	Multiple Myeloma 04/2012
1	Body Weight (Weight, Body) 04/2012
1	Hypoxia (Hypoxemia) 12/2001
1	Hematologic Neoplasms (Hematological Malignancy) 07/2001

Drug/Important Bio-Agent (IBA)

3	monorden (radicicol)IBA 12/2001 - 09/2000
2	KF58333IBA 12/2001 - 12/2001
2	OximesIBA 12/2001 - 09/2000
2	Proteins (Proteins, Gene)FDA Link 12/2001 - 09/2000
2	KT 1 (KT-1)IBA 07/2001 - 01/2000
2	Interferon-alpha (Interferon Alfa)IBA 07/2001 - 01/2000
1	KW-2478IBA 04/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2012
1	Bortezomib (Velcade)FDA Link 04/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2001
1	geldanamycinIBA 12/2001
1	Biological ProductsIBA 12/2001
1	Pharmaceutical PreparationsIBA 12/2001
1	NucleotidesIBA 12/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2000
1	Interferon-Stimulated Gene Factor 3IBA 01/2000
1	InterferonsIBA 01/2000

Therapy/Procedure

1	Therapeutics 04/2012
1	Intravenous Injections 12/2001